BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4217662)

  • 1. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
    Kano I; Yamakawa T
    Chem Phys Lipids; 1974 Dec; 13(4):283-91. PubMed ID: 4217662
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
    Johnson DL; Desnick RJ
    Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E; Schono N; Kozlova I; Wiederschain G
    Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
    Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
    Rietra PJ; Van den Bergh FA; Tager JM
    Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identity of alpha-galactosidase B from human liver.
    Schram AW; Hamers MN; Tager JM
    Biochim Biophys Acta; 1977 May; 482(1):138-44. PubMed ID: 405044
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
    Beutler E; Kuhl W; Matsumoto F; Pangalis G
    J Exp Med; 1976 Apr; 143(4):975-80. PubMed ID: 3620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry's disease: differentiation between two forms of -galactosidase by myoinositol.
    Crawhall JC; Banfalvi M
    Science; 1972 Aug; 177(4048):527-8. PubMed ID: 5050485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-D-galactosidase and beta-D-fucosidase of pig kidney.
    Wiederschain GY; Prokopenkov AA
    Arch Biochem Biophys; 1973 Oct; 158(2):539-43. PubMed ID: 4782520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mammalian glycosidases. 2. Ph-dependence and heat tolerance of alpha-mannosidase alpha-glucosidase and alpha-galactosidase activities of the extracts of the various organs of rats and rabbits].
    Suzuki I; Kushida H; Shida H
    Seikagaku; 1969 Jul; 41(7):334-41. PubMed ID: 5390042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical studies in Fabry's disease (author's transl)].
    Handa S
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1212-4. PubMed ID: 219278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
    Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone phenocopy of Fabry's keratopathy.
    Whitley CB; Tsai MY; Heger JJ; Prystowsky EN; Zipes DP
    JAMA; 1983 Apr 22-29; 249(16):2177-8. PubMed ID: 6300478
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
    Rietra PJ; Molenaar JL; Hamers MN; Tager JM; Borst P
    Eur J Biochem; 1974 Jul; 46(1):89-98. PubMed ID: 4212108
    [No Abstract]   [Full Text] [Related]  

  • 18. Human kidney alpha-galactosidase. Multiplicity and enzyme activities for ceramide trihexoside and some aryl alpha-galactosides.
    Kano I; Yamakawa T
    J Biochem; 1974 Feb; 75(2):347-54. PubMed ID: 4837447
    [No Abstract]   [Full Text] [Related]  

  • 19. Variables in the laboratory diagnosis of Fabry's disease by measurement of methylumbelliferyl-alpha-galactosidase activity.
    Brewster MA; Whaley SA; Kane AC
    Clin Chem; 1974 Mar; 20(3):383-6. PubMed ID: 4205035
    [No Abstract]   [Full Text] [Related]  

  • 20. Lysosomal acid hydrolases in the liver in gargoylism. Deficiency of 4-methylumbelliferyl-beta-galactosidase.
    Ockerman PA
    Scand J Clin Lab Invest; 1968; 22(2):142-6. PubMed ID: 4974670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.